Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
Renaud La Joie, Adrienne Visani, Orit H. Lesman‐Segev, et al.
Neurology (2020) Vol. 96, Iss. 5
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 871-881
Open Access | Times Cited: 549
Apolipoprotein E and Alzheimer's Disease: Findings, Hypotheses, and Potential Mechanisms
Nicole Koutsodendris, Maxine Nelson, Antara T. Rao, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 73-99
Closed Access | Times Cited: 159
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Daniel W. Sirkis, Luke W. Bonham, Taylor P. Johnson, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2674-2688
Open Access | Times Cited: 89
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 53
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 8
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 86
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Amelia Strom, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 713-728
Open Access | Times Cited: 68
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Rachel F. Buckley, Adrienne O’Donnell, Emer R. McGrath, et al.
Annals of Neurology (2022) Vol. 92, Iss. 1, pp. 11-22
Open Access | Times Cited: 61
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Alexandre Bejanin, M. Florencia Iulita, Eduard Vilaplana, et al.
JAMA Neurology (2021) Vol. 78, Iss. 8, pp. 937-937
Open Access | Times Cited: 57
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Lukas Frontzkowski, Michael Ewers, Matthias Brendel, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
Christina B. Young, Joseph R. Winer, Kyan Younes, et al.
JAMA Neurology (2022) Vol. 79, Iss. 6, pp. 592-592
Open Access | Times Cited: 51
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4489-4505
Open Access | Times Cited: 51
Association of APOE Genotypes and Chronic Traumatic Encephalopathy
Kathryn Atherton, Xudong Han, Jaeyoon Chung, et al.
JAMA Neurology (2022) Vol. 79, Iss. 8, pp. 787-787
Open Access | Times Cited: 46
APOE effects on regional tau in preclinical Alzheimer’s disease
Christina B. Young, Emily Johns, Gabriel Kennedy, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 38
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
Hanna Cho, Nidhi S. Mundada, Liana G. Apostolova, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. S9
Open Access | Times Cited: 32
The complex pathway between amyloid β and cognition: implications for therapy
William J. Jagust, Charlotte E. Teunissen, Charles DeCarli
The Lancet Neurology (2023) Vol. 22, Iss. 9, pp. 847-857
Open Access | Times Cited: 28
Diagnosis and Management of Posterior Cortical Atrophy
Keir Yong, Jonathan Graff‐Radford, Samrah Ahmed, et al.
Current Treatment Options in Neurology (2023) Vol. 25, Iss. 2, pp. 23-43
Open Access | Times Cited: 24
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries
Nicolas Villain, Robin Michalon
European Journal of Neurology (2024) Vol. 31, Iss. 11
Open Access | Times Cited: 12
Longitudinal Changes in Hippocampal Network Connectivity in Alzheimer's Disease
Sophie Dautricourt, Robin de Florès, Brigitte Landeau, et al.
Annals of Neurology (2021) Vol. 90, Iss. 3, pp. 391-406
Open Access | Times Cited: 41
Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults
Isabel J. Sible, Daniel A. Nation
Neurology (2022) Vol. 98, Iss. 24
Open Access | Times Cited: 31
Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study
Galit Weinstein, Adrienne O’Donnell, Kendra Davis‐Plourde, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 1371-1383
Closed Access | Times Cited: 29
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment
Nidhi S. Mundada, Julio C. Rojas, Lawren VandeVrede, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Alzheimer's disease phenotypes show different sleep architecture
Neus Falgàs, Christine M. Walsh, Leslie Yack, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3272-3282
Open Access | Times Cited: 19
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort
Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. S9
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top